FBLG FibroBiologics | $1.19
+4.4% | 2/27/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $16.00 -> $16.00 | Low | View details for D. Boral Capital rating of FibroBiologics (NASDAQ:FBLG) on 2/27/2025 |
IMNN Imunon | $0.81
+0.7% | 2/27/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $29.00 -> $29.00 | Medium | View details for D. Boral Capital rating of Imunon (NASDAQ:IMNN) on 2/27/2025 |
GOVX GeoVax Labs | $1.44
-2.7% | 2/27/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $18.00 -> $18.00 | Medium | View details for D. Boral Capital rating of GeoVax Labs (NASDAQ:GOVX) on 2/27/2025 |
TTI TETRA Technologies | $3.83
-2.7% | 2/27/2025 | Reiterated by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $5.50 -> $5.50 | Medium | View details for D. Boral Capital rating of TETRA Technologies (NYSE:TTI) on 2/27/2025 |
MSAI MultiSensor AI | $1.24
| 2/26/2025 | Initiated by | D. Boral Capital | Analyst Jesse Sobelson | Buy | $2.50 | Low | View details for D. Boral Capital rating of MultiSensor AI (NASDAQ:MSAI) on 2/26/2025 |
IMUX Immunic | $1.12
-4.3% | 2/26/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $17.00 -> $17.00 | Medium | View details for D. Boral Capital rating of Immunic (NASDAQ:IMUX) on 2/26/2025 |
HUMA Humacyte | $3.37
-1.7% | 2/26/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $25.00 -> $25.00 | High | View details for D. Boral Capital rating of Humacyte (NASDAQ:HUMA) on 2/26/2025 |
KAPA Kairos Pharma | $1.21
-2.4% | 2/26/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | N/A | View details for D. Boral Capital rating of Kairos Pharma (NYSEAMERICAN:KAPA) on 2/26/2025 |
NOTE FiscalNote | $1.21
-4.4% | 2/25/2025 | Target Raised by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $3.50 -> $3.75 | Low | View details for D. Boral Capital rating of FiscalNote (NYSE:NOTE) on 2/25/2025 |
NNOX Nano-X Imaging | $6.03
-5.8% | 2/25/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $23.00 -> $23.00 | High | View details for D. Boral Capital rating of Nano-X Imaging (NASDAQ:NNOX) on 2/25/2025 |
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. |
CMPX Compass Therapeutics | $2.92
-1.7% | 2/25/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $32.00 -> $32.00 | High | View details for D. Boral Capital rating of Compass Therapeutics (NASDAQ:CMPX) on 2/25/2025 |
CTSO Cytosorbents | $1.07
-2.7% | 2/25/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $10.00 -> $10.00 | Low | View details for D. Boral Capital rating of Cytosorbents (NASDAQ:CTSO) on 2/25/2025 |
CLNN Clene | $4.42
+3.5% | 2/25/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $23.00 -> $23.00 | High | View details for D. Boral Capital rating of Clene (NASDAQ:CLNN) on 2/25/2025 |
TRVI Trevi Therapeutics | $4.50
-0.2% | 2/24/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $21.00 -> $21.00 | High | View details for D. Boral Capital rating of Trevi Therapeutics (NASDAQ:TRVI) on 2/24/2025 |
IVVD Invivyd | $1.24
+0.8% | 2/24/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | Medium | View details for D. Boral Capital rating of Invivyd (NASDAQ:IVVD) on 2/24/2025 |
MNOV MediciNova | $1.68
+1.2% | 2/21/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | High | View details for D. Boral Capital rating of MediciNova (NASDAQ:MNOV) on 2/21/2025 |
OMER Omeros | $8.52
-2.6% | 2/20/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $36.00 -> $36.00 | High | View details for D. Boral Capital rating of Omeros (NASDAQ:OMER) on 2/20/2025 |
IMUX Immunic | $1.12
-4.3% | 2/20/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $17.00 -> $17.00 | High | View details for D. Boral Capital rating of Immunic (NASDAQ:IMUX) on 2/20/2025 |
RCEL AVITA Medical | $8.90
-7.5% | 2/20/2025 | Target Lowered by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $25.00 -> $22.00 | High | View details for D. Boral Capital rating of AVITA Medical (NASDAQ:RCEL) on 2/20/2025 |
OSTX OS Therapies | $1.64
-1.2% | 2/20/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $20.00 -> $20.00 | Low | View details for D. Boral Capital rating of OS Therapies (NYSE:OSTX) on 2/20/2025 |
IMNN Imunon | $0.81
+0.7% | 2/19/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $29.00 -> $29.00 | High | View details for D. Boral Capital rating of Imunon (NASDAQ:IMNN) on 2/19/2025 |
CRVO CervoMed | $2.21
| 2/19/2025 | Upgraded by | D. Boral Capital | Analyst Jason Kolbert | Hold -> Buy | $10.00 | High | View details for D. Boral Capital rating of CervoMed (NASDAQ:CRVO) on 2/19/2025 |
KAPA Kairos Pharma | $1.21
-2.4% | 2/18/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | N/A | View details for D. Boral Capital rating of Kairos Pharma (NYSEAMERICAN:KAPA) on 2/18/2025 |
MSAI MultiSensor AI | $1.24
| 2/18/2025 | Initiated by | D. Boral Capital | Analyst Jesse Sobelson | Buy | $2.50 | High | View details for D. Boral Capital rating of MultiSensor AI (NASDAQ:MSAI) on 2/18/2025 |
CTXR Citius Pharmaceuticals | $1.63
-0.6% | 2/18/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | High | View details for D. Boral Capital rating of Citius Pharmaceuticals (NASDAQ:CTXR) on 2/18/2025 |
ESLA Estrella Immunopharma | $0.96
-12.7% | 2/18/2025 | Initiated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $16.00 -> $16.00 | High | View details for D. Boral Capital rating of Estrella Immunopharma (NASDAQ:ESLA) on 2/18/2025 |
URGN UroGen Pharma | $9.29
-0.7% | 2/18/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $25.00 -> $25.00 | High | View details for D. Boral Capital rating of UroGen Pharma (NASDAQ:URGN) on 2/18/2025 |
IBRX ImmunityBio | $2.86
-4.7% | 2/14/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $30.00 -> $30.00 | High | View details for D. Boral Capital rating of ImmunityBio (NASDAQ:IBRX) on 2/14/2025 |
RCEL AVITA Medical | $8.90
-7.5% | 2/14/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $25.00 -> $25.00 | High | View details for D. Boral Capital rating of AVITA Medical (NASDAQ:RCEL) on 2/14/2025 |
FBLG FibroBiologics | $1.19
+4.4% | 2/13/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $16.00 -> $16.00 | High | View details for D. Boral Capital rating of FibroBiologics (NASDAQ:FBLG) on 2/13/2025 |
URGN UroGen Pharma | $9.29
-0.7% | 2/12/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $25.00 -> $25.00 | Medium | View details for D. Boral Capital rating of UroGen Pharma (NASDAQ:URGN) on 2/12/2025 |
CLGN CollPlant Biotechnologies | $3.50
-0.3% | 2/12/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $14.00 -> $14.00 | High | View details for D. Boral Capital rating of CollPlant Biotechnologies (NASDAQ:CLGN) on 2/12/2025 |
KAPA Kairos Pharma | $1.21
-2.4% | 2/12/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | N/A | View details for D. Boral Capital rating of Kairos Pharma (NYSEAMERICAN:KAPA) on 2/12/2025 |
AVXL Anavex Life Sciences | $7.85
-2.7% | 2/12/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $46.00 -> $46.00 | High | View details for D. Boral Capital rating of Anavex Life Sciences (NASDAQ:AVXL) on 2/12/2025 |
LCTX Lineage Cell Therapeutics | $0.57
-8.3% | 2/11/2025 | Target Lowered by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $3.00 -> $2.00 | N/A | View details for D. Boral Capital rating of Lineage Cell Therapeutics (NYSEAMERICAN:LCTX) on 2/11/2025 |
ANVS Annovis Bio | $1.79
+2.6% | 2/10/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Hold | | High | View details for D. Boral Capital rating of Annovis Bio (NYSE:ANVS) on 2/10/2025 |
MVIS MicroVision | $1.37
-4.2% | 2/10/2025 | Initiated by | D. Boral Capital | Analyst Jesse Sobelson | Buy | $3.00 | High | View details for D. Boral Capital rating of MicroVision (NASDAQ:MVIS) on 2/10/2025 |
ENLV Enlivex Therapeutics | $1.03
+3.0% | 2/7/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $13.00 -> $13.00 | High | View details for D. Boral Capital rating of Enlivex Therapeutics (NASDAQ:ENLV) on 2/7/2025 |
VNRX VolitionRx | $0.64
+9.5% | 2/6/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $5.00 -> $5.00 | High | View details for D. Boral Capital rating of VolitionRx (NYSE:VNRX) on 2/6/2025 |
COYA Coya Therapeutics | $6.73
+12.2% | 2/6/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $15.00 -> $15.00 | Low | View details for D. Boral Capital rating of Coya Therapeutics (NASDAQ:COYA) on 2/6/2025 |
A market crash is coming—here’s when (Ad) The stock market cycle I've used to identify the most likely day of the next market crash is the exact same indicator that helped me call the bear market of 2018... the bull market in 2020... the bear market in 2022... the roaring bull markets in 2023 and 2024... and more. I'm convinced it has helped me identify the next big crash too. We are at an important juncture in the markets. Knowing what to do in the months to come is critical. Click here to check out my full write-up. |
CLNN Clene | $4.42
+3.5% | 2/6/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $23.00 -> $23.00 | Low | View details for D. Boral Capital rating of Clene (NASDAQ:CLNN) on 2/6/2025 |
QNCX Quince Therapeutics | $1.39
+4.5% | 2/5/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $12.00 -> $12.00 | High | View details for D. Boral Capital rating of Quince Therapeutics (NASDAQ:QNCX) on 2/5/2025 |
CLGN CollPlant Biotechnologies | $3.50
-0.3% | 2/4/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $14.00 -> $14.00 | High | View details for D. Boral Capital rating of CollPlant Biotechnologies (NASDAQ:CLGN) on 2/4/2025 |
IVVD Invivyd | $1.24
+0.8% | 2/3/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | High | View details for D. Boral Capital rating of Invivyd (NASDAQ:IVVD) on 2/3/2025 |
VERI Veritone | $2.68
-2.5% | 2/3/2025 | Initiated by | D. Boral Capital | Analyst Jesse Sobelson | Buy | $4.50 | High | View details for D. Boral Capital rating of Veritone (NASDAQ:VERI) on 2/3/2025 |
GOVX GeoVax Labs | $1.44
-2.7% | 1/31/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $18.00 -> $18.00 | Medium | View details for D. Boral Capital rating of GeoVax Labs (NASDAQ:GOVX) on 1/31/2025 |
OSTX OS Therapies | $1.64
-1.2% | 1/30/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $20.00 -> $20.00 | High | View details for D. Boral Capital rating of OS Therapies (NYSE:OSTX) on 1/30/2025 |
VNRX VolitionRx | $0.64
+9.5% | 1/29/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $5.00 -> $5.00 | Low | View details for D. Boral Capital rating of VolitionRx (NYSE:VNRX) on 1/29/2025 |
NRXP NRx Pharmaceuticals | $2.29
-5.8% | 1/28/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $31.00 -> $31.00 | High | View details for D. Boral Capital rating of NRx Pharmaceuticals (NASDAQ:NRXP) on 1/28/2025 |
AVXL Anavex Life Sciences | $7.85
-2.7% | 1/28/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $46.00 -> $46.00 | Medium | View details for D. Boral Capital rating of Anavex Life Sciences (NASDAQ:AVXL) on 1/28/2025 |
IBRX ImmunityBio | $2.86
-4.7% | 1/27/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $30.00 -> $30.00 | Medium | View details for D. Boral Capital rating of ImmunityBio (NASDAQ:IBRX) on 1/27/2025 |
IVVD Invivyd | $1.24
+0.8% | 1/27/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | High | View details for D. Boral Capital rating of Invivyd (NASDAQ:IVVD) on 1/27/2025 |
SCLX Scilex | $0.23
-15.6% | 1/27/2025 | Initiated by | D. Boral Capital | Analyst Jason Kolbert | Buy | $22.00 | Medium | View details for D. Boral Capital rating of Scilex (NASDAQ:SCLX) on 1/27/2025 |
IMNN Imunon | $0.81
+0.7% | 1/24/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $29.00 -> $29.00 | High | View details for D. Boral Capital rating of Imunon (NASDAQ:IMNN) on 1/24/2025 |
USEG U.S. Energy | $1.60
-4.8% | 1/24/2025 | Reiterated by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $3.50 -> $3.50 | Low | View details for D. Boral Capital rating of U.S. Energy (NASDAQ:USEG) on 1/24/2025 |
URGN UroGen Pharma | $9.29
-0.7% | 1/23/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $25.00 -> $25.00 | High | View details for D. Boral Capital rating of UroGen Pharma (NASDAQ:URGN) on 1/23/2025 |
KAPA Kairos Pharma | $1.21
-2.4% | 1/22/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | N/A | View details for D. Boral Capital rating of Kairos Pharma (NYSEAMERICAN:KAPA) on 1/22/2025 |
ANIX Anixa Biosciences | $3.07
+0.7% | 1/22/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $10.00 -> $10.00 | High | View details for D. Boral Capital rating of Anixa Biosciences (NASDAQ:ANIX) on 1/22/2025 |
CRMD CorMedix | $10.25
-2.8% | 1/22/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $15.00 -> $15.00 | Medium | View details for D. Boral Capital rating of CorMedix (NASDAQ:CRMD) on 1/22/2025 |
COYA Coya Therapeutics | $6.73
+12.2% | 1/21/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $15.00 -> $15.00 | Medium | View details for D. Boral Capital rating of Coya Therapeutics (NASDAQ:COYA) on 1/21/2025 |
HUMA Humacyte | $3.37
-1.7% | 1/21/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $25.00 -> $25.00 | Low | View details for D. Boral Capital rating of Humacyte (NASDAQ:HUMA) on 1/21/2025 |
RVPH Reviva Pharmaceuticals | $1.43
+6.7% | 1/21/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $15.00 -> $15.00 | High | View details for D. Boral Capital rating of Reviva Pharmaceuticals (NASDAQ:RVPH) on 1/21/2025 |
CXDO Crexendo | $6.24
-6.4% | 1/21/2025 | Initiated by | D. Boral Capital | Analyst Jesse Sobelson | Buy | $7.00 | High | View details for D. Boral Capital rating of Crexendo (NASDAQ:CXDO) on 1/21/2025 |
OMER Omeros | $8.52
-2.6% | 1/16/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $36.00 -> $36.00 | Medium | View details for D. Boral Capital rating of Omeros (NASDAQ:OMER) on 1/16/2025 |
IBRX ImmunityBio | $2.86
-4.7% | 1/16/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $30.00 -> $30.00 | High | View details for D. Boral Capital rating of ImmunityBio (NASDAQ:IBRX) on 1/16/2025 |
NOTE FiscalNote | $1.21
-4.4% | 1/16/2025 | Reiterated by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $3.50 -> $3.50 | High | View details for D. Boral Capital rating of FiscalNote (NYSE:NOTE) on 1/16/2025 |
GOVX GeoVax Labs | $1.44
-2.7% | 1/16/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $18.00 -> $18.00 | Low | View details for D. Boral Capital rating of GeoVax Labs (NASDAQ:GOVX) on 1/16/2025 |
URGN UroGen Pharma | $9.29
-0.7% | 1/15/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $25.00 -> $25.00 | High | View details for D. Boral Capital rating of UroGen Pharma (NASDAQ:URGN) on 1/15/2025 |
OSTX OS Therapies | $1.64
-1.2% | 1/15/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $20.00 -> $20.00 | High | View details for D. Boral Capital rating of OS Therapies (NYSE:OSTX) on 1/15/2025 |
HOVR New Horizon Aircraft | $0.50
+6.5% | 1/15/2025 | Reiterated by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $2.00 -> $2.00 | Medium | View details for D. Boral Capital rating of New Horizon Aircraft (NASDAQ:HOVR) on 1/15/2025 |
CNTX Context Therapeutics | $0.81
-4.7% | 1/15/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | High | View details for D. Boral Capital rating of Context Therapeutics (NASDAQ:CNTX) on 1/15/2025 |
ANIX Anixa Biosciences | $3.07
+0.7% | 1/14/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $10.00 -> $10.00 | High | View details for D. Boral Capital rating of Anixa Biosciences (NASDAQ:ANIX) on 1/14/2025 |
HUMA Humacyte | $3.37
-1.7% | 1/13/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $25.00 -> $25.00 | High | View details for D. Boral Capital rating of Humacyte (NASDAQ:HUMA) on 1/13/2025 |
CARM Carisma Therapeutics | $0.41
-3.9% | 1/13/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $12.00 -> $12.00 | Medium | View details for D. Boral Capital rating of Carisma Therapeutics (NASDAQ:CARM) on 1/13/2025 |
AVXL Anavex Life Sciences | $7.85
-2.7% | 1/13/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $46.00 -> $46.00 | High | View details for D. Boral Capital rating of Anavex Life Sciences (NASDAQ:AVXL) on 1/13/2025 |
CKPT Checkpoint Therapeutics | $2.71
-2.5% | 1/13/2025 | Initiated by | D. Boral Capital | Analyst Jason Kolbert | Buy | $9.00 | Medium | View details for D. Boral Capital rating of Checkpoint Therapeutics (NASDAQ:CKPT) on 1/13/2025 |
CRMD CorMedix | $10.25
-2.8% | 1/13/2025 | Initiated by | D. Boral Capital | Analyst Jason Kolbert | Buy | $15.00 | Low | View details for D. Boral Capital rating of CorMedix (NASDAQ:CRMD) on 1/13/2025 |
USEG U.S. Energy | $1.60
-4.8% | 1/13/2025 | Reiterated by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $2.00 -> $2.00 | High | View details for D. Boral Capital rating of U.S. Energy (NASDAQ:USEG) on 1/13/2025 |
CTSO Cytosorbents | $1.07
-2.7% | 1/13/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $10.00 -> $10.00 | High | View details for D. Boral Capital rating of Cytosorbents (NASDAQ:CTSO) on 1/13/2025 |
BMEA Biomea Fusion | $2.80
-1.6% | 1/10/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $128.00 -> $128.00 | High | View details for D. Boral Capital rating of Biomea Fusion (NASDAQ:BMEA) on 1/10/2025 |
IVVD Invivyd | $1.24
+0.8% | 1/10/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | Low | View details for D. Boral Capital rating of Invivyd (NASDAQ:IVVD) on 1/10/2025 |
HOVR New Horizon Aircraft | $0.50
+6.5% | 1/8/2025 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $2.00 -> $2.00 | Low | View details for D. Boral Capital rating of New Horizon Aircraft (NASDAQ:HOVR) on 1/8/2025 |
VNRX VolitionRx | $0.64
+9.5% | 1/8/2025 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $5.00 -> $5.00 | High | View details for D. Boral Capital rating of VolitionRx (NYSE:VNRX) on 1/8/2025 |
CMPX Compass Therapeutics | $2.92
-1.7% | 1/8/2025 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $32.00 -> $32.00 | High | View details for D. Boral Capital rating of Compass Therapeutics (NASDAQ:CMPX) on 1/8/2025 |
TRVI Trevi Therapeutics | $4.50
-0.2% | 1/8/2025 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $21.00 -> $21.00 | Medium | View details for D. Boral Capital rating of Trevi Therapeutics (NASDAQ:TRVI) on 1/8/2025 |
TTI TETRA Technologies | $3.83
-2.7% | 1/8/2025 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $5.50 -> $5.50 | Medium | View details for D. Boral Capital rating of TETRA Technologies (NYSE:TTI) on 1/8/2025 |
RCEL AVITA Medical | $8.90
-7.5% | 1/8/2025 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $25.00 -> $25.00 | High | View details for D. Boral Capital rating of AVITA Medical (NASDAQ:RCEL) on 1/8/2025 |
CTXR Citius Pharmaceuticals | $1.63
-0.6% | 1/7/2025 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $9.00 -> $9.00 | High | View details for D. Boral Capital rating of Citius Pharmaceuticals (NASDAQ:CTXR) on 1/7/2025 |
IMUX Immunic | $1.12
-4.3% | 1/7/2025 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $17.00 -> $17.00 | Medium | View details for D. Boral Capital rating of Immunic (NASDAQ:IMUX) on 1/7/2025 |
AREC American Resources | $0.57
+7.5% | 1/7/2025 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $4.00 -> $4.00 | Low | View details for D. Boral Capital rating of American Resources (NASDAQ:AREC) on 1/7/2025 |
A market crash is coming—here’s when (Ad) The stock market cycle I've used to identify the most likely day of the next market crash is the exact same indicator that helped me call the bear market of 2018... the bull market in 2020... the bear market in 2022... the roaring bull markets in 2023 and 2024... and more. I'm convinced it has helped me identify the next big crash too. We are at an important juncture in the markets. Knowing what to do in the months to come is critical. Click here to check out my full write-up. |
IBRX ImmunityBio | $2.86
-4.7% | 1/6/2025 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $30.00 -> $30.00 | N/A | View details for D. Boral Capital rating of ImmunityBio (NASDAQ:IBRX) on 1/6/2025 |
NRXP NRx Pharmaceuticals | $2.29
-5.8% | 1/6/2025 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $31.00 -> $31.00 | N/A | View details for D. Boral Capital rating of NRx Pharmaceuticals (NASDAQ:NRXP) on 1/6/2025 |
NNOX Nano-X Imaging | $6.03
-5.8% | 1/6/2025 | Initiated by | D. Boral Capital | - | Buy | $23.00 | N/A | View details for D. Boral Capital rating of Nano-X Imaging (NASDAQ:NNOX) on 1/6/2025 |
CTSO Cytosorbents | $1.07
-2.7% | 1/3/2025 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $10.00 -> $10.00 | N/A | View details for D. Boral Capital rating of Cytosorbents (NASDAQ:CTSO) on 1/3/2025 |
LCTX Lineage Cell Therapeutics | $0.57
-8.3% | 1/3/2025 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $2.00 -> $2.00 | N/A | View details for D. Boral Capital rating of Lineage Cell Therapeutics (NYSEAMERICAN:LCTX) on 1/3/2025 |
USEG U.S. Energy | $1.60
-4.8% | 1/3/2025 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $2.00 -> $2.00 | N/A | View details for D. Boral Capital rating of U.S. Energy (NASDAQ:USEG) on 1/3/2025 |
QNCX Quince Therapeutics | $1.39
+4.5% | 1/2/2025 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $12.00 -> $12.00 | N/A | View details for D. Boral Capital rating of Quince Therapeutics (NASDAQ:QNCX) on 1/2/2025 |
NRXP NRx Pharmaceuticals | $2.29
-5.8% | 12/31/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $31.00 -> $31.00 | N/A | View details for D. Boral Capital rating of NRx Pharmaceuticals (NASDAQ:NRXP) on 12/31/2024 |
HOVR New Horizon Aircraft | $0.50
+6.5% | 12/30/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $2.00 -> $2.00 | N/A | View details for D. Boral Capital rating of New Horizon Aircraft (NASDAQ:HOVR) on 12/30/2024 |
CTXR Citius Pharmaceuticals | $1.63
-0.6% | 12/30/2024 | Upgraded by | D. Boral Capital | - | Hold -> Buy | $9.00 | N/A | View details for D. Boral Capital rating of Citius Pharmaceuticals (NASDAQ:CTXR) on 12/30/2024 |
FBLG FibroBiologics | $1.19
+4.4% | 12/27/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $16.00 -> $16.00 | N/A | View details for D. Boral Capital rating of FibroBiologics (NASDAQ:FBLG) on 12/27/2024 |
RCEL AVITA Medical | $8.90
-7.5% | 12/24/2024 | Initiated by | D. Boral Capital | - | Buy | $25.00 | N/A | View details for D. Boral Capital rating of AVITA Medical (NASDAQ:RCEL) on 12/24/2024 |
AVXL Anavex Life Sciences | $7.85
-2.7% | 12/23/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $46.00 -> $46.00 | N/A | View details for D. Boral Capital rating of Anavex Life Sciences (NASDAQ:AVXL) on 12/23/2024 |
CMPX Compass Therapeutics | $2.92
-1.7% | 12/23/2024 | Initiated by | D. Boral Capital | - | Buy | $32.00 | N/A | View details for D. Boral Capital rating of Compass Therapeutics (NASDAQ:CMPX) on 12/23/2024 |
OMER Omeros | $8.52
-2.6% | 12/23/2024 | Initiated by | D. Boral Capital | - | Buy | $36.00 | N/A | View details for D. Boral Capital rating of Omeros (NASDAQ:OMER) on 12/23/2024 |
IBRX ImmunityBio | $2.86
-4.7% | 12/20/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $30.00 -> $30.00 | N/A | View details for D. Boral Capital rating of ImmunityBio (NASDAQ:IBRX) on 12/20/2024 |
RZLV Rezolve AI | $1.95
-10.1% | 12/20/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $8.00 -> $8.00 | N/A | View details for D. Boral Capital rating of Rezolve AI (NASDAQ:RZLV) on 12/20/2024 |
HUMA Humacyte | $3.37
-1.7% | 12/20/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $25.00 -> $25.00 | N/A | View details for D. Boral Capital rating of Humacyte (NASDAQ:HUMA) on 12/20/2024 |
IMNN Imunon | $0.81
+0.7% | 12/19/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $29.00 -> $29.00 | N/A | View details for D. Boral Capital rating of Imunon (NASDAQ:IMNN) on 12/19/2024 |
CLNN Clene | $4.42
+3.5% | 12/19/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $23.00 -> $23.00 | N/A | View details for D. Boral Capital rating of Clene (NASDAQ:CLNN) on 12/19/2024 |
COYA Coya Therapeutics | $6.73
+12.2% | 12/18/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $15.00 -> $15.00 | N/A | View details for D. Boral Capital rating of Coya Therapeutics (NASDAQ:COYA) on 12/18/2024 |
GOVX GeoVax Labs | $1.44
-2.7% | 12/18/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $18.00 -> $18.00 | N/A | View details for D. Boral Capital rating of GeoVax Labs (NASDAQ:GOVX) on 12/18/2024 |
TTI TETRA Technologies | $3.83
-2.7% | 12/17/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $5.50 -> $5.50 | N/A | View details for D. Boral Capital rating of TETRA Technologies (NYSE:TTI) on 12/17/2024 |
BMEA Biomea Fusion | $2.80
-1.6% | 12/17/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $128.00 -> $128.00 | N/A | View details for D. Boral Capital rating of Biomea Fusion (NASDAQ:BMEA) on 12/17/2024 |
ICFI ICF International | $99.97
-0.9% | 12/16/2024 | Reiterated by | D. Boral Capital | - | Outperform -> Outperform | $174.00 -> $174.00 | N/A | View details for D. Boral Capital rating of ICF International (NASDAQ:ICFI) on 12/16/2024 |
TRVI Trevi Therapeutics | $4.50
-0.2% | 12/12/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $21.00 -> $21.00 | N/A | View details for D. Boral Capital rating of Trevi Therapeutics (NASDAQ:TRVI) on 12/12/2024 |
ENLV Enlivex Therapeutics | $1.03
+3.0% | 12/11/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $13.00 -> $13.00 | N/A | View details for D. Boral Capital rating of Enlivex Therapeutics (NASDAQ:ENLV) on 12/11/2024 |
CLNN Clene | $4.42
+3.5% | 12/10/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $23.00 -> $23.00 | N/A | View details for D. Boral Capital rating of Clene (NASDAQ:CLNN) on 12/10/2024 |
VNRX VolitionRx | $0.64
+9.5% | 12/10/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $5.00 -> $5.00 | N/A | View details for D. Boral Capital rating of VolitionRx (NYSE:VNRX) on 12/10/2024 |
IMNN Imunon | $0.81
+0.7% | 12/10/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $29.00 -> $29.00 | N/A | View details for D. Boral Capital rating of Imunon (NASDAQ:IMNN) on 12/10/2024 |
CRVO CervoMed | $2.21
| 12/10/2024 | Reiterated by | D. Boral Capital | - | Buy -> Hold | | N/A | View details for D. Boral Capital rating of CervoMed (NASDAQ:CRVO) on 12/10/2024 |
BMEA Biomea Fusion | $2.80
-1.6% | 12/10/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $128.00 -> $128.00 | N/A | View details for D. Boral Capital rating of Biomea Fusion (NASDAQ:BMEA) on 12/10/2024 |
CARM Carisma Therapeutics | $0.41
-3.9% | 12/9/2024 | Target Lowered by | D. Boral Capital | - | Buy -> Buy | $24.00 -> $12.00 | N/A | View details for D. Boral Capital rating of Carisma Therapeutics (NASDAQ:CARM) on 12/9/2024 |
URGN UroGen Pharma | $9.29
-0.7% | 12/6/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $25.00 -> $25.00 | N/A | View details for D. Boral Capital rating of UroGen Pharma (NASDAQ:URGN) on 12/6/2024 |
TRVI Trevi Therapeutics | $4.50
-0.2% | 12/4/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $21.00 -> $21.00 | N/A | View details for D. Boral Capital rating of Trevi Therapeutics (NASDAQ:TRVI) on 12/4/2024 |
COYA Coya Therapeutics | $6.73
+12.2% | 12/4/2024 | Initiated by | D. Boral Capital | - | Buy | $15.00 | N/A | View details for D. Boral Capital rating of Coya Therapeutics (NASDAQ:COYA) on 12/4/2024 |
ENLV Enlivex Therapeutics | $1.03
+3.0% | 12/3/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $13.00 -> $13.00 | N/A | View details for D. Boral Capital rating of Enlivex Therapeutics (NASDAQ:ENLV) on 12/3/2024 |
MNOV MediciNova | $1.68
+1.2% | 12/2/2024 | Initiated by | D. Boral Capital | - | Buy -> Buy | $9.00 -> $9.00 | N/A | View details for D. Boral Capital rating of MediciNova (NASDAQ:MNOV) on 12/2/2024 |
CRVO CervoMed | $2.21
| 11/27/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $34.00 -> $34.00 | N/A | View details for D. Boral Capital rating of CervoMed (NASDAQ:CRVO) on 11/27/2024 |
CLGN CollPlant Biotechnologies | $3.50
-0.3% | 11/27/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $14.00 -> $14.00 | N/A | View details for D. Boral Capital rating of CollPlant Biotechnologies (NASDAQ:CLGN) on 11/27/2024 |
AVXL Anavex Life Sciences | $7.85
-2.7% | 11/25/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $46.00 -> $46.00 | N/A | View details for D. Boral Capital rating of Anavex Life Sciences (NASDAQ:AVXL) on 11/25/2024 |
IMNN Imunon | $0.81
+0.7% | 11/25/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $29.00 -> $29.00 | N/A | View details for D. Boral Capital rating of Imunon (NASDAQ:IMNN) on 11/25/2024 |
GOVX GeoVax Labs | $1.44
-2.7% | 11/19/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $18.00 -> $18.00 | N/A | View details for D. Boral Capital rating of GeoVax Labs (NASDAQ:GOVX) on 11/19/2024 |
ANIX Anixa Biosciences | $3.07
+0.7% | 11/19/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $10.00 -> $10.00 | N/A | View details for D. Boral Capital rating of Anixa Biosciences (NASDAQ:ANIX) on 11/19/2024 |
BMEA Biomea Fusion | $2.80
-1.6% | 11/19/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $128.00 -> $128.00 | N/A | View details for D. Boral Capital rating of Biomea Fusion (NASDAQ:BMEA) on 11/19/2024 |
PED PEDEVCO | $0.78
+5.8% | 11/20/2024 | Target Lowered by | D. Boral Capital | - | Buy -> Buy | $2.25 -> $1.50 | N/A | View details for D. Boral Capital rating of PEDEVCO (NYSE:PED) on 11/20/2024 |
FBLG FibroBiologics | $1.19
+4.4% | 11/20/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $16.00 -> $16.00 | N/A | View details for D. Boral Capital rating of FibroBiologics (NASDAQ:FBLG) on 11/20/2024 |
LCTX Lineage Cell Therapeutics | $0.57
-8.3% | 11/20/2024 | Target Lowered by | D. Boral Capital | - | Buy -> Buy | $3.00 -> $2.00 | N/A | View details for D. Boral Capital rating of Lineage Cell Therapeutics (NYSEAMERICAN:LCTX) on 11/20/2024 |
IVVD Invivyd | $1.24
+0.8% | 11/21/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $9.00 -> $9.00 | N/A | View details for D. Boral Capital rating of Invivyd (NASDAQ:IVVD) on 11/21/2024 |
HUMA Humacyte | $3.37
-1.7% | 11/21/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $25.00 -> $25.00 | N/A | View details for D. Boral Capital rating of Humacyte (NASDAQ:HUMA) on 11/21/2024 |
A market crash is coming—here’s when (Ad) The stock market cycle I've used to identify the most likely day of the next market crash is the exact same indicator that helped me call the bear market of 2018... the bull market in 2020... the bear market in 2022... the roaring bull markets in 2023 and 2024... and more. I'm convinced it has helped me identify the next big crash too. We are at an important juncture in the markets. Knowing what to do in the months to come is critical. Click here to check out my full write-up. |
IBRX ImmunityBio | $2.86
-4.7% | 11/21/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $30.00 -> $30.00 | N/A | View details for D. Boral Capital rating of ImmunityBio (NASDAQ:IBRX) on 11/21/2024 |
AREC American Resources | $0.57
+7.5% | 11/21/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $4.00 -> $4.00 | N/A | View details for D. Boral Capital rating of American Resources (NASDAQ:AREC) on 11/21/2024 |
CTXR Citius Pharmaceuticals | $1.63
-0.6% | 11/22/2024 | Reiterated by | D. Boral Capital | - | Buy -> Hold | | N/A | View details for D. Boral Capital rating of Citius Pharmaceuticals (NASDAQ:CTXR) on 11/22/2024 |
CNTX Context Therapeutics | $0.81
-4.7% | 11/25/2024 | Initiated by | D. Boral Capital | - | Buy | $9.00 | N/A | View details for D. Boral Capital rating of Context Therapeutics (NASDAQ:CNTX) on 11/25/2024 |
